Loading…
Banaras Hindu University, Varanasi, secured approval for six biomedical research grants from the Indian Council of Medical Research on 20 August 2026.
The grants total about Rs 15 crore and are led mainly by the university's Institute of Medical Sciences.
The projects cover early detection of gallbladder cancer, antimicrobial resistance, post-kala-azar dermal leishmaniasis diagnostics, paediatric septic shock and precision oncology for renal cell carcinoma.
The work will use cohort studies, precision clinical trials, multi-omics biomarker discovery and laboratory analyses, drawing in the Institute of Science and collaborating engineering departments.
ICMR, India's apex biomedical research body, was founded in 1911 as the Indian Research Fund Association and took its present name in 1949.
India's apex body for the formulation, coordination and promotion of biomedical research; funds extramural projects through competitive grants
Central university whose Institute of Medical Sciences is a major centre for clinical research and postgraduate medical training
A biomarker is any measurable signal - a molecule in blood, a pattern of gene expression - that reliably indicates a disease state or predicts how a patient will respond to treatment. Older studies looked at one layer at a time, usually genes. Multi-omics combines several: genomics for the DNA sequence, transcriptomics for what is being read out of it, proteomics for the proteins produced, and metabolomics for the chemical products of cell activity. Combining them raises the chance of finding a signal that shows up early, which is precisely what a cancer like gallbladder carcinoma, usually detected late, requires.
Simple Analogy: Diagnosing an engine fault from the sound alone is guesswork; listening while also reading temperature, pressure and fuel flow finds it much sooner.
GS Paper III > Science and Technology - developments and their applications; GS Paper II > Health
General Awareness > Institutions and General Science - Biology
General Science > Biology - diseases; General Awareness > Institutions
The ability of bacteria, viruses, fungi or parasites to survive drugs that were previously effective against them, rendering standard treatments ineffective.
A skin manifestation that can follow treatment for visceral leishmaniasis; affected persons can serve as a reservoir of the parasite.
Treating cancer on the basis of the molecular profile of an individual tumour rather than by cancer type alone.
Research funding awarded by an agency such as ICMR to investigators in outside institutions, as opposed to work done in the agency's own laboratories.